# Mark Cuban Cost Plus Drug Company, PBC

Canonical: https://abierto.us/vendors/mark-cuban-cost-plus-drug-company-pbc-n8p7mq937wn7

- UEI: N8P7MQ937WN7
- CAGE: 9VYL8
- Location: Dallas, TX
- Awards in window: 2 (3 transactions), $1,599,179 obligated, June 11, 2025 to May 8, 2026

## Awarding agencies

- Department of the Army: 2 awards, $1,599,179

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $1,393,259
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $205,920

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- W911SR26CA011 (definitive contract): $1,393,259, W6QK ACC-APG. Mark Cuban Cost Plus Drug Company (Mccpdc) Intends to Generate a Chemistry, Manufacturing, and Controls (Cmc) Data Package Suitable for an FDA Abbreviated New Drug Application (Anda).. https://www.usaspending.gov/award/CONT_AWD_W911SR26CA011_9700_-NONE-_-NONE-/
- W911SR25CA006 (definitive contract): $205,920, W6QK ACC-APG. This Contract Is for Proof of Concept Production of Drug Substance Sterile Saline and Sterile Water Using Nonsterile Source Water Made Under Current Good Manufacturing Practice Regulations.. https://www.usaspending.gov/award/CONT_AWD_W911SR25CA006_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/mark-cuban-cost-plus-drug-company-pbc-n8p7mq937wn7.